Magdalena Klánová

1.1k total citations
38 papers, 721 citations indexed

About

Magdalena Klánová is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Magdalena Klánová has authored 38 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 17 papers in Oncology and 16 papers in Genetics. Recurrent topics in Magdalena Klánová's work include Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Viral-associated cancers and disorders (8 papers). Magdalena Klánová is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Viral-associated cancers and disorders (8 papers). Magdalena Klánová collaborates with scholars based in Czechia, Germany and Switzerland. Magdalena Klánová's co-authors include Pavel Klener, Marek Trněný, Tina Nielsen, Günter Fingerle‐Rowson, Petra Vočková, Ladislav Anděra, Jan Molinský, Robert Marcus, Wolfgang Hiddemann and Dana Průková and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Magdalena Klánová

35 papers receiving 713 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Klánová Czechia 12 397 346 252 231 130 38 721
Kedar Inamdar United States 15 276 0.7× 253 0.7× 156 0.6× 393 1.7× 141 1.1× 39 772
Amanda Copeland United States 15 558 1.4× 623 1.8× 315 1.3× 536 2.3× 166 1.3× 36 1.2k
S. Öhl Germany 13 378 1.0× 234 0.7× 264 1.0× 216 0.9× 179 1.4× 19 778
James Q. Wang Australia 9 579 1.5× 392 1.1× 273 1.1× 222 1.0× 288 2.2× 12 904
Beata Holkova United States 13 297 0.7× 307 0.9× 139 0.6× 222 1.0× 87 0.7× 48 634
Helle Toldbod Denmark 9 513 1.3× 405 1.2× 145 0.6× 191 0.8× 244 1.9× 13 804
Alicja Gruszka Italy 20 380 1.0× 259 0.7× 378 1.5× 395 1.7× 112 0.9× 36 945
Chengfeng Bi China 12 325 0.8× 256 0.7× 88 0.3× 162 0.7× 97 0.7× 29 536
Beth Christian United States 18 682 1.7× 521 1.5× 404 1.6× 132 0.6× 207 1.6× 84 979
Giuseppe Dastoli Italy 15 241 0.6× 284 0.8× 133 0.5× 251 1.1× 154 1.2× 23 806

Countries citing papers authored by Magdalena Klánová

Since Specialization
Citations

This map shows the geographic impact of Magdalena Klánová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Klánová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Klánová more than expected).

Fields of papers citing papers by Magdalena Klánová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Klánová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Klánová. The network helps show where Magdalena Klánová may publish in the future.

Co-authorship network of co-authors of Magdalena Klánová

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Klánová. A scholar is included among the top collaborators of Magdalena Klánová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Klánová. Magdalena Klánová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jakša, Radek, et al.. (2025). The journey of patients with diffuse large B-cell lymphoma: from symptoms to diagnosis. Leukemia & lymphoma. 66(7). 1293–1299.
2.
Cyprys, Philipp, Marc‐André Kasper, Magdalena Klánová, et al.. (2025). TUB-010, a Novel Anti-CD30 Antibody–Drug Conjugate Based on Tub-Tag Technology, Widens the Therapeutic Window by Reducing Toxicity While Maintaining High Efficacy. Molecular Cancer Therapeutics. 25(2). 216–229.
3.
Májovský, Martin, et al.. (2024). Surgical results in patients with CNS lymphoma. Comparison of predictive value of intraoperative MRI and intraoperative histological examination for diagnostic biopsy yield. SHILAP Revista de lepidopterología. 4. 103926–103926. 1 indexed citations
4.
Klánová, Magdalena, et al.. (2023). Risk of Central Nervous System Vs. Systemic Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: What Should We Focus on?. Blood. 142(Supplement 1). 4479–4479. 1 indexed citations
5.
Svatoň, Michael, Kristina Forsterová, Tomáš Heizer, et al.. (2023). Sequencing‐based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy. American Journal of Hematology. 98(10). 1627–1636. 10 indexed citations
6.
Klánová, Magdalena, et al.. (2023). DLBCL Patients' Journey: From Symptoms to Diagnosis. Blood. 142(Supplement 1). 3140–3140.
7.
Průková, Dana, Ladislav Anděra, Zuzana Nahácka, et al.. (2019). Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma. Clinical Cancer Research. 25(14). 4455–4465. 63 indexed citations
8.
Klánová, Magdalena, Mikkel Z. Oestergaard, Marek Trněný, et al.. (2019). Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy. Clinical Cancer Research. 25(15). 4634–4643. 54 indexed citations
9.
Bolen, Christopher R., Magdalena Klánová, Marek Trněný, et al.. (2019). Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study. Haematologica. 105(9). 2298–2307. 30 indexed citations
10.
Klánová, Magdalena, Laurie H. Sehn, Isabelle Bence‐Bruckler, et al.. (2019). Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. Blood. 133(9). 919–926. 75 indexed citations
11.
Hiddemann, Wolfgang, Anna Maria Barbui, Miguel Canales, et al.. (2018). Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety. Journal of Clinical Oncology. 36(23). 2395–2404. 144 indexed citations
12.
Hiddemann, Wolfgang, Anna Maria Barbui, Miguel Canales, et al.. (2017). Immunochemotherapy With Obinutuzumab Or Rituximab In Previously Untreated Follicular Lymphoma In The Randomized Phase III Gallium Study: Analysis By Chemotherapy Regimen. Haematologica. 1 indexed citations
13.
Klánová, Magdalena, Laurie H. Sehn, Federica Cavallo, et al.. (2017). CELL OF ORIGIN COMBINED WITH CNS INTERNATIONAL PROGNOSTIC INDEX IMPROVES IDENTIFICATION OF DLBCL PATIENTS WITH HIGH CNS RELAPSE RISK AFTER INITIAL IMMUNOCHEMOTHERAPY. Hematological Oncology. 35(S2). 43–44. 1 indexed citations
14.
Klánová, Magdalena, Tomáš Soukup, Jan Molinský, et al.. (2016). Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model. Neoplasma. 63(5). 774–778. 1 indexed citations
15.
Klánová, Magdalena, Ladislav Anděra, Jan Bražina, et al.. (2015). Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma. Clinical Cancer Research. 22(5). 1138–1149. 72 indexed citations
16.
Ščigelová, Michaela, Tabiwang N. Arrey, Jana Pospíšilová, et al.. (2015). Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells. PLoS ONE. 10(8). e0135314–e0135314. 9 indexed citations
17.
Klánová, Magdalena, Tomáš Soukup, Radek Jakša, et al.. (2014). Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research. Laboratory Investigation. 94(7). 806–817. 24 indexed citations
18.
Molinský, Jan, Magdalena Klánová, Tomáš Soukup, et al.. (2013). In Vivo Growth of Mantle Cell Lymphoma Xenografts in Immunodeficient Mice Is Positively Regulated by VEGF and Associated with Significant Up-regulation of CD31/PECAM1. Folia Biologica. 59(1). 26–31. 4 indexed citations
19.
Molinský, Jan, Magdalena Klánová, Ladislav Anděra, et al.. (2012). Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL). Neoplasma. 60(2). 223–231. 8 indexed citations
20.
Molinský, Jan, Magdalena Klánová, Michal Koc, et al.. (2012). Roscovitine sensitizes leukemia and lymphoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Leukemia & lymphoma. 54(2). 372–380. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kedar Inamdar Breakdown of academic impact, for papers by Amanda Copeland Breakdown of academic impact, for papers by S. Öhl Breakdown of academic impact, for papers by James Q. Wang Breakdown of academic impact, for papers by Beata Holkova Breakdown of academic impact, for papers by Helle Toldbod Breakdown of academic impact, for papers by Alicja Gruszka Breakdown of academic impact, for papers by Chengfeng Bi Breakdown of academic impact, for papers by Beth Christian Breakdown of academic impact, for papers by Giuseppe Dastoli
Rankless by CCL
2026